Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
about
Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine.Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography.Tau PET imaging: present and future directions.Mating and memory: an educational primer for use with "epigenetic control of learning and memory in Drosophila by Tip60 HAT action"Amyloid polymorphism: structural basis and neurobiological relevance.Childhood Learning Disabilities and Atypical Dementia: A Retrospective Chart ReviewCombined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 MiceCognitive Results of CANTAB Tests and Their Change Due to the First Dose of Donepezil May Predict Treatment Efficacy in Alzheimer Disease.Back to the future: Alzheimer's disease heterogeneity revisited.When a Little Knowledge Can Be Dangerous: False-Positive Diagnosis of Behavioral Variant Frontotemporal Dementia among Community Clinicians.Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.Specific Features of Executive Dysfunction in Alzheimer-Type Mild Dementia Based on Computerized Cambridge Neuropsychological Test Automated Battery (CANTAB) Test Results.Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.Early-onset dementias: diagnostic and etiological considerations.Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.Diagnosing the frontal variant of Alzheimer's disease: a clinician's yellow brick road.Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.Biomarker-driven therapeutic management of Alzheimer's disease: establishing the foundations.Biomarker modelling of early molecular changes in Alzheimer's disease.Linguistic Features Identify Alzheimer's Disease in Narrative Speech.Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease.Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside.Alzheimers' disease and caregiving: a meta-analytic review comparing the mental health of primary carers to controls.Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.Long-term acupuncture treatment has a multi-targeting regulation on multiple brain regions in rats with Alzheimer's disease: a positron emission tomography study.Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.The putative role of environmental aluminium in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved?Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.Studies for Improving a Rat Model of Alzheimer's Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory.Trehalose protects against cadmium-induced cytotoxicity in primary rat proximal tubular cells via inhibiting apoptosis and restoring autophagic flux.A new data analysis approach for measuring longitudinal changes of metabolism in cognitively normal elderly adults.Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's disease.Differential Contributions of Selective Attention and Sensory Integration to Driving Performance in Healthy Aging and Alzheimer's Disease.Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease.Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.Stem Cell Technology for (Epi)genetic Brain Disorders.Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.Spontaneous confabulations in amnestic-mild cognitive impairment due to Alzheimer's disease: a new (yet old) atypical variant?
P2860
Q30366183-A46FE644-3A43-49B5-80B9-AF9409014BDDQ34378321-DFC547E9-EC32-44B0-8347-DC3463BAAADBQ34680852-D90B595A-C218-447B-8442-4069E8539F53Q35579797-6426B631-32B8-488C-852D-501FC488453AQ35586308-E44B0834-80EE-4649-A82C-4ACF4917DC57Q35672676-14BF7F51-FC79-49BA-98A9-E13120678768Q36065117-5DECF860-2172-4FE9-B1F0-E41D6357DAC1Q36384458-CDB576FE-1819-499B-BBC9-62141981FF06Q36785505-661852F6-F418-4656-A250-77345BB864FAQ36808475-FFE7B953-E8D6-4072-A482-5EE52C4E3F76Q37127867-BA3FA718-8571-4A5D-AB21-4F120F318DD3Q37337804-65C95084-3E78-4009-8B09-9FBD07EEA5A6Q37369443-6180E568-F449-4F3E-9D2C-3E11F9F4BCF1Q37606162-7AF7335C-417F-4873-B399-4DE4BA30024AQ37639685-95DCEF71-4A05-477A-B6EF-24BAF7420014Q37676759-13B8C4C6-5C2A-44B9-9E6F-383644264D05Q37693146-C2F0A506-5A43-448D-8387-255544A0FBDBQ38150708-B4AF1061-CAAB-4354-8369-2B6A8DD44F7CQ38166669-1170A277-A0B0-46BD-B90B-54C909A61931Q38401648-23FBEC61-F19A-4BE4-A725-4E36439EDA9EQ38654257-1D56A299-DB58-4210-8D0F-BBDFBB9E05B6Q38802634-3677CEA7-E7DA-43DB-81A5-7F7C249295DFQ39432592-F729487F-CA00-4A93-A479-A28A22399F31Q40058055-CFAC42EA-D650-4CCC-8710-307B69A01066Q40283684-4DD47A06-AC2E-4F64-8A09-4C6EA697002AQ41429910-E61D8F33-49BD-4EED-A4F6-41AD8A0D089AQ41538249-CAE051B0-6342-445D-BA1E-4F36AC1E23C5Q41689625-2DE45112-7AB2-44EE-88F2-2F4FB5E91D05Q45949141-9FA87B07-C929-4003-B0B4-2B334D38169DQ46257963-E5408D81-CED3-4214-A9BE-BBCAB1D699B2Q47142884-7AA876BB-4B57-41A7-BDA8-8F4FDBAFC041Q47144813-95024BEC-E2BF-442F-AFE3-FE9AB3568320Q47222878-B9AF4CB0-319C-4462-80A7-FD3CF0E05A14Q47240379-7568712C-718E-4BB6-B7C9-0039BA42D3F4Q47381323-B53C7C9E-2BB6-4EA3-831C-C38F4A83BB56Q47655932-96D2E6EE-17BE-4A4B-8CF8-2F155D56C115Q47718746-805F3B63-6296-4CAF-BCAF-CF6B847F4D6FQ48609636-984C8C72-4575-473C-893A-CBCD0BE00375Q48881691-0014E056-3B7C-44A2-AFDB-762F577BA420Q50621953-AC51454D-B1D6-4D7A-8068-ED30EF2E9243
P2860
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
@ast
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
@en
type
label
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
@ast
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
@en
prefLabel
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
@ast
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
@en
P2093
P2860
P356
P1476
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.
@en
P2093
Benjamin Lam
Donald T Stuss
Mario Masellis
Morris Freedman
P2860
P2888
P356
10.1186/ALZRT155
P407
P50
P577
2013-01-09T00:00:00Z
P5875
P6179
1004793367